The diagnosis and treatment of non-tuberculous mycobacterium disease in children

doi:10.3969/j.issn.1000-6621.2021.09.021

Abstract

ZHENG Hui-wen, SHEN A-dong. The diagnosis and treatment of non-tuberculous mycobacterium disease in children[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 979-982. doi: 10.3969/j.issn.1000-6621.2021.09.021

References 26

[1]	Saxena S, Spaink HP, Forn-Cuní G. Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models. Biology (Basel), 2021, 10(2):96. doi: 10.3390/biology10020096. doi: 10.3390/biology10020096
[2]	Tebruegge M, Pantazidou A, MacGregor D, et al. Nontuberculous Mycobacterial Disease in Children-Epidemiology, Diagnosis & Management at a Tertiary Center. PLoS One, 2016, 11(1):e0147513. doi: 10.1371/journal.pone.0147513. doi: 10.1371/journal.pone.0147513 URL
[3]	Haverkamp MH, Arend SM, Lindeboom JA, et al. Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis, 2004, 39(4):450-456. doi: 10.1086/422319. doi: 10.1086/422319 pmid: 15356803
[4]	Pham-Huy A, Robinson JL, Tapiéro B, et al. Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health, 2010, 15(5):276-282. doi: 10.1093/pch/15.5.276. doi: 10.1093/pch/15.5.276 URL
[5]	Reuss AM, Wiese-Posselt M, Weissmann B, et al. Incidence rate of nontuberculous mycobacterial disease in immunocompetent children: a prospective nationwide surveillance study in Germany. Pediatr Infect Dis J, 2009, 28(7):642-644. doi: 10.1097/INF.0b013e3181978e8e. doi: 10.1097/INF.0b013e3181978e8e URL
[6]	Asiimwe BB, Bagyenzi GB, Ssengooba W, et al. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda. BMC Infect Dis, 2013, 13:88. doi: 10.1186/1471-2334-13-88. doi: 10.1186/1471-2334-13-88 pmid: 23413873
[7]	王宇. 全国第五次结核病流行病学抽样调查资料汇编. 北京: 军事医学科学出版社, 2011: 15-18.
[8]	Zimmermann P, Curtis N, Tebruegge M. Nontuberculous mycobacterial disease in childhood-update on diagnostic approaches and treatment. J Infect, 2017, 74 Suppl 1: S136-S142. doi: 10.1016/S0163-4453(17)30204-9. doi: 10.1016/S0163-4453(17)30204-9
[9]	Loizos A, Soteriades ES, Pieridou D, et al. Lymphadenitis by non-tuberculous mycobacteria in children. Pediatr Int, 2018, 60(12):1062-1067. doi: 10.1111/ped.13708. doi: 10.1111/ped.13708
[10]	López-Varela E, García-Basteiro AL, Santiago B, et al. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. Lancet Respir Med, 2015, 3(3):244-256. doi: 10.1016/S2213-2600(15)00062-4. doi: 10.1016/S2213-2600(15)00062-4 URL
[11]	Danielides V, Patrikakos G, Moerman M, et al. Diagnosis, management and surgical treatment of non-tuberculous mycobacterial head and neck infection in children. ORL J Otorhinolaryngol Relat Spec, 2002, 64(4):284-289. doi: 10.1159/000064138. doi: 10.1159/000064138 URL
[12]	Willemse SH, Oomens MAEM, De Lange J, et al. Diagnosing nontuberculous mycobacterial cervicofacial lymphadenitis in children: A systematic review. Int J Pediatr Otorhinolaryngol, 2018, 112:48-54. doi: 10.1016/j.ijporl.2018.06.034. doi: 10.1016/j.ijporl.2018.06.034 URL
[13]	Chung J, Ince D, Ford BA, et al. Cutaneous Infections Due to Nontuberculosis Mycobacterium: Recognition and Management. Am J Clin Dermatol, 2018, 19(6):867-878. doi: 10.1007/s40257-018-0382-5. doi: 10.1007/s40257-018-0382-5 pmid: 30168084
[14]	Santa Cruz DJ, Strayer DS. The histologic spectrum of the cutaneous mycobacterioses. Hum Pathol, 1982, 13(5):485-495. doi: 10.1016/s0046-8177(82)80032-4. doi: 10.1016/s0046-8177(82)80032-4 pmid: 6804365
[15]	Lu M, Saddi V, Britton PN, et al. Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis. Paediatr Respir Rev, 2019, 29:42-52. doi: 10.1016/j.prrv.2018.05.001. doi: 10.1016/j.prrv.2018.05.001
[16]	Martiniano SL, Davidson RM, Nick JA. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward. Pediatr Pulmonol, 2017, 52(S48):S29-S36. doi: 10.1002/ppul.23825. doi: 10.1002/ppul.23825 URL
[17]	Morgan MB, Reves RR, Wilson ML, et al. Comparison of BACTEC 12B vs solid media for the recovery of Mycobacterium avium complex from blood cultures in AIDS patients. Diagn Microbiol Infect Dis, 1997, 28(1):45-48. doi: 10.1016/s0732-8893(97)89159-6. doi: 10.1016/s0732-8893(97)89159-6 URL
[18]	Schoenfeld N, Haas W, Richter E, et al. Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses. Pneumo-logie, 2016, 70(4):250-276. doi: 10.1055/s-0041-111494. doi: 10.1055/s-0041-111494
[19]	Zimmermann P, Tebruegge M, Curtis N, et al. The management of non-tuberculous cervicofacial lymphadenitis in children: A systematic review and meta-analysis. J Infect, 2015, 71(1):9-18. doi: 10.1016/j.jinf.2015.02.010. doi: 10.1016/j.jinf.2015.02.010 pmid: 25727993
[20]	Torretta S, Gaffuri M, Ibba T, et al. Surgical treatment of non-tuberculous mycobacterial lymphadenitis in children: Our experience and a narrative review. Int J Immunopathol Pharmacol, 2018, 32:2058738418806413. doi: 10.1177/2058738418806413. doi: 10.1177/2058738418806413
[21]	Meoli A, Deolmi M, Iannarella R, et al. Non-Tuberculous Mycobacterial Diseases in Children. Pathogens, 2020, 9(7):553. doi: 10.3390/pathogens9070553. doi: 10.3390/pathogens9070553 URL
[22]	Andrew EC, Connell T, Robinson P, et al. Pulmonary Mycobacterium abscessus complex in children with cystic fibrosis: A practical management guideline. J Paediatr Child Health, 2019, 55(5):502-511. doi: 10.1111/jpc.14427. doi: 10.1111/jpc.14427 URL
[23]	Lindeboom JA. Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis, 2011, 52(2):180-184. doi: 10.1093/cid/ciq070. doi: 10.1093/cid/ciq070 pmid: 21288841
[24]	Shafran SD, Singer J, Zarowny DP, et al. A Comparison of Two Regimens for the Treatment of Mycobacterium avium Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin. N Engl J Med, 1996, 335:377-383. doi: 10.1056/NEJM199608083350602. doi: 10.1056/NEJM199608083350602 URL
[25]	Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly activeantiretroviral therapy. Lancet Infect Dis, 2004, 4:557-565. doi: 10.1016/S1473-3099(04)01130-2. doi: 10.1016/S1473-3099(04)01130-2 pmid: 15336223
[26]	Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med, 2007, 175(4):367-416. doi: 10.1164/rccm.200604-571ST. doi: 10.1164/rccm.200604-571ST URL

The diagnosis and treatment of non-tuberculous mycobacterium disease in children

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 26

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	LIU Fang, RAO Xiao-chun, MA Yu-yan, MENG Chen-fang, PAN Yue-na, JIAO An-xia, SHEN A-dong. Evaluation of the effectiveness of bronchoscopy in the treatment of lymph node fistula tracheobronchial tuberculosis in children [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 826-831.
[2]	WANG Ya-cui, SUN Lin, SHEN A-dong. Application progress of Xpert MTB/RIF Ultra assay in tuberculosis diagnosis in children [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 843-846.
[3]	LIN Yan, DENG Guo-fang. Issues that need attention in the multi-sector approaches on providing anti-tuberculosis treatment for patients with diabetes mellitus-tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 649-652.
[4]	QI Xue, WU Xi-rong, GUO Ya-jie, WANG Yong-hong, MA Qi, CHEN Yu-ying, SUN Lin, SHEN A-dong. Analysis of screening of latent tuberculosis infection in hospitalized children [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 653-658.
[5]	QIN Yao, CAI Qing-shan, BAO Zhi-jian. Analysis of clinical characteristics and prognosis of 21 pregnant women complicated with tuberculosis after in vitro fertilization-embryo transfer [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 682-688.
[6]	FANG Min, SHI Yan, DUAN Li, SHI Xiao-mei, QUAN Shu-ting, WANG Ya-cui, PENG Xiao-shan, JIA Ji-hang, QI Hui, JIAO Wei-wei, ZHU Yu, SUN Lin. Diagnostic value of GeneXpert MTB/RIF Ultra for pulmonary tuberculosis in children using gastric juice [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 584-589.
[7]	XUE Hai-bin, LUO Xiao-bo, SUN Fei, JIAN Wei, LI Jin-long. Analysis of clinical efficacy of posterior transforaminal debridement and interbody fusion with instrumentation via tubular retractor system for lumbar tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 457-462.
[8]	YANG Hong, MA Jin-bao, REN Fei, LI Xue, WU Yan-qin, LI Rong, TAN Gan-wen, YANG Han. Classified evaluation of the effect of standard anti-tuberculosis regimen in the treatment of initial multidrug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 495-500.
[9]	MA Yan*, GAO Wei-wei. Pay attention to the reasonable treatment of retreatment tuberculosis:today is not what it used to be [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 313-317.
[10]	SHU Wei, GE Qi-ping, HUANG Xue-rui, MA Li-ping, JI Bin-ying, CHEN Yu-hui, CHEN Xiao-you, JIANG Guang-lu, XIE Li, LI Bo, CHEN Sheng-yu, CHEN Sen-lin, YAN Jun-ping, SHI Lian, CHEN Ling, LI You-lun, XI Xiu-e, LIU Qian-ying, YAN Xing-lu, WANG Fei, WANG Fu-rong, WU Xiang, ZHANG Peng, LENG Xue-yan, CAO Wen-li, ZHANG Hai-qing, CUI Hong-zhe, YANG Cheng-qing, WU Chao, LI Juan, LI Hua, SUN Yu-xian, ZHANG Li-jie, XIE Shi-heng, NING Yu-jia, TIAN Xi-zhong, DU Jian, LI Liang, GAO Wei-wei. Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistance [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 322-327.
[11]	GE Qi-ping*, DU Jian, SHU Wei, MA Yan, MA Li-ping, ZHAO Cai-yan, CHEN Yu-hui, ZHANG Li-jie, HUANG Xue-rui, HAN Xi-qin, CHEN Sheng-yu, WANG Fei, LI Bo, CAO Wen-li, LIU Qian-ying, CHEN Dong-jin, SHI Lian, WANG Xin, LI You-lun, YANG Shang-peng, PENG Zhang-li, WU Chao, OUYANG Bing, WANG Fu-rong, LI Po, WU Xiang, XI Xiu-e, LENG Xue-yan, ZHANG Hai-qing, LI Hua, LI Juan, YANG Cheng-qing, ZHANG Peng, CUI Hong-zhe, XIE Li, LIU Yu-hong, LI Liang, GAO Wei-wei. Treatment effect analysis of the optimized regimen for re-treated drug-susceptible pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 328-334.
[12]	ZHANG Li-jie*, HAN Xi-qin, WANG Jing-ping, CHEN Yu-hui, CHEN Sheng-yu, CHEN Ling, LI Bo, LIN Ming-gui, LI You-lun, SHI Lian, XI Xiu-e, MA Li-ping, WANG Xin, WANG Fei, ZHAO Cai-yan, WANG Fu-rong, CHEN Sen-lin, WU Xiang, LI Po, ZHANG Peng, LENG Xue-yan, ZHANG Hai-qing, CAO Wen-li, SHU Wei, SUN Yu-xian, XIE Shi-heng, TIAN Xi-zhong, HUANG Xue-rui, DU Jian, GAO Wei-wei. The relationship between bacterial load and treatment failure and recurrence of sputum positive retreatment pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 335-340.
[13]	Maiweilanjiang· Abulimiti, Diermulati· Tusun, LIU Zhen-jiang, Xirizhati· Mamuti, LI Guan-zhen, OU Xi-chao. Analysis on the therapeutic effect and influencing factors of initial treated smear-positive pulmonary tuberculosis patients in Kashgar Prefecture from 2016 to 2018 [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 391-397.
[14]	YANG Ni, SU Qian, XIAO Yue, LU Jia, SONG Yang, RAO Zheng-yuan, XIA Lan, HE Jin-ge, CHEN Chuang, ZHANG Ling-lin. Analysis on treatment outcomes and influencing factors of 2158 patients with MTB/HIV co-infection [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 274-279.
[15]	MI Jie, XUE Yong, BAI Xue-juan, WU Xue-qiong. The research progress of lymphocyte subsets detection in diagnosis and treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 178-185.